- Fenofibric acid
-
- $30.00/ kg
-
2024-04-22
- CAS:42017-89-0
- Min. Order: 1kg
- Purity: 99.7%
- Supply Ability: 200000kg
- Fenofibric acid
-
- $0.00 / 1kg
-
2023-12-12
- CAS:42017-89-0
- Min. Order: 1kg
- Purity: 99.5
- Supply Ability: 500000kg
- Fenofibrate Acid
-
- $100.00 / 25KG
-
2023-01-31
- CAS:42017-89-0
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 5000kg/week
|
| | Fenofibric acid Basic information |
| | Fenofibric acid Chemical Properties |
| Melting point | 177-179°C | | Boiling point | 486.5±35.0 °C(Predicted) | | density | 1.286±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | Chloroform (Slightly), Methanol (Slightly) | | pka | 3.09±0.10(Predicted) | | form | powder | | color | White to Off-White | | BRN | 2058973 | | CAS DataBase Reference | 42017-89-0(CAS DataBase Reference) |
| Hazard Codes | Xn,N | | Risk Statements | 36/37/38-50/53-22 | | Safety Statements | 26-36/37/39-61-60-24/25 | | RIDADR | UN 3077 9 / PGIII | | WGK Germany | 3 | | RTECS | UA2453000 | | HazardClass | 9 | | PackingGroup | III | | HS Code | 29189900 | | Toxicity | LD50 oral in rat: 1242mg/kg |
| | Fenofibric acid Usage And Synthesis |
| Chemical Properties | White to Off-White Solid | | Uses | Fenofibric acid, the active metabolite of fenofibrate. Increases Apolipoprotein A-I–Mediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptor–dependent manner. | | Uses | Fenofibric acid, the active metabolite of fenofibrate. Increases Apolipoprotein A-Iediated High-Density Lipoprotein Biogenesis by enhancing transcription of ATP-Binding cassette transporter A1 gene in a liver X receptorependent manner | | Uses | DPP4 inhibitor, antidiabetic | | Definition | ChEBI: A monocarboxylic acid that is 2-methylpropanoic acid substituted by a 4-(4-chlorobenzoyl)phenoxy group at position 2. It is a metabolite of the drug fenofibrate. |
| | Fenofibric acid Preparation Products And Raw materials |
|